Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01405092
Other study ID # #09-097
Secondary ID
Status Completed
Phase N/A
First received July 28, 2011
Last updated August 7, 2012
Start date April 2010
Est. completion date August 2012

Study information

Verified date August 2012
Source Dallas VA Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Use of on-line blood volume monitoring during continuous renal replacement therapy can improve volume management in acute kidney injury patients requiring renal replacement


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Patients with kidney injury requiring continuous renal replacement therapy and volume removal

Exclusion Criteria:

- unable to provide or obtain patient consent

- not expected to survive 48 hours

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Continuous Renal Replacement Therapy

Intervention

Device:
use of continuous renal replacement machine for renal replacement
usual care with volume removal during continuous renal replacement therapy
use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal
blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal

Locations

Country Name City State
United States Dallas VA Medical Center Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
Dallas VA Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary compare number of hypotensive events in treatment versus control arms compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period 24 hour for each arm Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT04537975 - C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19 N/A
Recruiting NCT02034448 - CRRTNet Registry- A Prospective Observational Registry N/A
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Withdrawn NCT04103307 - Continuous Renal Replacement Therapy for Acute Kidney Injury by Cooling Blood Phase 2
Not yet recruiting NCT04315623 - RCA for CRRT in Hyperlactatemia Patient With Increased Bleeding Risk N/A
Recruiting NCT05450185 - Filter Lifespan in Continuous Renal Replacement Therapy
Recruiting NCT06021080 - Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions
Not yet recruiting NCT06369064 - Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient N/A
Not yet recruiting NCT06425289 - Macrohemodynamic Impact of Fluid Removal With Net Ultrafiltration in Patients With Continuous Renal Replacement Therapy
Completed NCT04959110 - Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT N/A
Recruiting NCT03897582 - Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study
Recruiting NCT03144349 - Diagnosis Accuracy of Hemoconcentration to Detect Hypovolemia During CRRT
Completed NCT04071171 - Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation Phase 2
Completed NCT03314363 - Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry N/A
Completed NCT04792424 - No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation N/A